These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 7603034)
1. Induction of senescent cell-derived inhibitor of DNA synthesis gene, SDI1, in hepatoblastoma (HepG2) cells arrested in the G2-phase of the cell cycle by 9-nitrocamptothecin. Khaoustov VI; Ozer A; Smith JR; Noda A; Mearns M; Krishnan B; Slagle BL; Yoffe B Lab Invest; 1995 Jul; 73(1):118-27. PubMed ID: 7603034 [TBL] [Abstract][Full Text] [Related]
2. Cytotoxic efficacy of 9-nitrocamptothecin in the treatment of human malignant melanoma cells in vitro. Pantazis P; Early JA; Mendoza JT; DeJesus AR; Giovanella BC Cancer Res; 1994 Feb; 54(3):771-6. PubMed ID: 8306340 [TBL] [Abstract][Full Text] [Related]
3. Regression of human breast carcinoma tumors in immunodeficient mice treated with 9-nitrocamptothecin: differential response of nontumorigenic and tumorigenic human breast cells in vitro. Pantazis P; Early JA; Kozielski AJ; Mendoza JT; Hinz HR; Giovanella BC Cancer Res; 1993 Apr; 53(7):1577-82. PubMed ID: 8453626 [TBL] [Abstract][Full Text] [Related]
4. IP6 in treatment of liver cancer. I. IP6 inhibits growth and reverses transformed phenotype in HepG2 human liver cancer cell line. Vucenik I; Tantivejkul K; Zhang ZS; Cole KE; Saied I; Shamsuddin AM Anticancer Res; 1998; 18(6A):4083-90. PubMed ID: 9891449 [TBL] [Abstract][Full Text] [Related]
5. The investigational new drug XK469 induces G(2)-M cell cycle arrest by p53-dependent and -independent pathways. Ding Z; Parchment RE; LoRusso PM; Zhou JY; Li J; Lawrence TS; Sun Y; Wu GS Clin Cancer Res; 2001 Nov; 7(11):3336-42. PubMed ID: 11705845 [TBL] [Abstract][Full Text] [Related]
6. p21Waf1/Cip1/Sdi1 induces permanent growth arrest with markers of replicative senescence in human tumor cells lacking functional p53. Fang L; Igarashi M; Leung J; Sugrue MM; Lee SW; Aaronson SA Oncogene; 1999 May; 18(18):2789-97. PubMed ID: 10362249 [TBL] [Abstract][Full Text] [Related]
7. Polyamine depletion in human melanoma cells leads to G1 arrest associated with induction of p21WAF1/CIP1/SDI1, changes in the expression of p21-regulated genes, and a senescence-like phenotype. Kramer DL; Chang BD; Chen Y; Diegelman P; Alm K; Black AR; Roninson IB; Porter CW Cancer Res; 2001 Nov; 61(21):7754-62. PubMed ID: 11691789 [TBL] [Abstract][Full Text] [Related]
8. Regulation of cyclin-dependent kinase inhibitor p21(WAF1/Cip1/Sdi1) gene expression in hepatic regeneration. Albrecht JH; Meyer AH; Hu MY Hepatology; 1997 Mar; 25(3):557-63. PubMed ID: 9049198 [TBL] [Abstract][Full Text] [Related]
9. The melanoma differentiation-associated gene mda-6, which encodes the cyclin-dependent kinase inhibitor p21, is differentially expressed during growth, differentiation and progression in human melanoma cells. Jiang H; Lin J; Su ZZ; Herlyn M; Kerbel RS; Weissman BE; Welch DR; Fisher PB Oncogene; 1995 May; 10(9):1855-64. PubMed ID: 7753561 [TBL] [Abstract][Full Text] [Related]
10. A chenodeoxycholic derivative, HS-1200, induces apoptosis and cell cycle modulation via Egr-1 gene expression control on human hepatoma cells. Park SE; Lee SW; Hossain MA; Kim MY; Kim MN; Ahn EY; Park YC; Suh H; Kim GY; Choi YH; Kim ND Cancer Lett; 2008 Oct; 270(1):77-86. PubMed ID: 18554781 [TBL] [Abstract][Full Text] [Related]
11. Growth inhibition of human hepatoma cells by acyclic retinoid is associated with induction of p21(CIP1) and inhibition of expression of cyclin D1. Suzui M; Masuda M; Lim JT; Albanese C; Pestell RG; Weinstein IB Cancer Res; 2002 Jul; 62(14):3997-4006. PubMed ID: 12124333 [TBL] [Abstract][Full Text] [Related]
12. [Synergistic inhibitory effect of all-trans retinoic acid and 1,25-dihydroxy vitamin D3 on growth of human hepatoma cell line HepG2]. Lu HQ; Zheng J Ai Zheng; 2006 Dec; 25(12):1470-6. PubMed ID: 17166369 [TBL] [Abstract][Full Text] [Related]
13. Emodin-induced apoptosis through p53-dependent pathway in human hepatoma cells. Shieh DE; Chen YY; Yen MH; Chiang LC; Lin CC Life Sci; 2004 Mar; 74(18):2279-90. PubMed ID: 14987952 [TBL] [Abstract][Full Text] [Related]
14. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB. Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544 [TBL] [Abstract][Full Text] [Related]
15. Suramin increases p53 protein levels but does not activate the p53-dependent G1 checkpoint. Howard SP; Park SJ; Hughes-Davies L; Coleman CN; Price BD Clin Cancer Res; 1996 Feb; 2(2):269-76. PubMed ID: 9816169 [TBL] [Abstract][Full Text] [Related]
16. Induction of apoptosis by the p53-273L (Arg --> Leu) mutant in HSC3 cells without transactivation of p21Waf1/Cip1/Sdi1 and bax. Kaneuchi M; Yamashita T; Shindoh M; Segawa K; Takahashi S; Furuta I; Fujimoto S; Fujinaga K Mol Carcinog; 1999 Sep; 26(1):44-52. PubMed ID: 10487521 [TBL] [Abstract][Full Text] [Related]
17. Andrographolide induces cell cycle arrest at G2/M phase and cell death in HepG2 cells via alteration of reactive oxygen species. Li J; Cheung HY; Zhang Z; Chan GK; Fong WF Eur J Pharmacol; 2007 Jul; 568(1-3):31-44. PubMed ID: 17512926 [TBL] [Abstract][Full Text] [Related]
18. p21 binding to PCNA causes G1 and G2 cell cycle arrest in p53-deficient cells. Cayrol C; Knibiehler M; Ducommun B Oncogene; 1998 Jan; 16(3):311-20. PubMed ID: 9467956 [TBL] [Abstract][Full Text] [Related]
19. Differential GADD45, p21CIP1/WAF1, MCL-1 and topoisomerase II gene induction and secondary DNA fragmentation after camptothecin-induced DNA damage in two mutant p53 human colon cancer cell lines. Goldwasser F; Bae I; Fornace AJ; Pommier Y Oncol Res; 1996; 8(7-8):317-23. PubMed ID: 8938795 [TBL] [Abstract][Full Text] [Related]
20. Interleukin-2 expression in human carcinoma cell lines and its role in cell cycle progression. Reichert TE; Nagashima S; Kashii Y; Stanson J; Gao G; Dou QP; Whiteside TL Oncogene; 2000 Jan; 19(4):514-25. PubMed ID: 10698521 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]